HemaSphere
(Jun 2022)
P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS
- J. Senapati,
- S. Verstovsek,
- L. Masarova,
- N. Pemmaraju,
- G. Montalban Bravo,
- S. Pierce,
- L. Zhou,
- G. Garcia-Manero,
- H. Kantarjian,
- P. Bose
Affiliations
- J. Senapati
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- S. Verstovsek
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- L. Masarova
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- N. Pemmaraju
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- G. Montalban Bravo
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- S. Pierce
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- L. Zhou
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- G. Garcia-Manero
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- H. Kantarjian
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- P. Bose
- 1 Leukemia, MD Anderson Cancer Center, Houston, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000847076.55141.3b
- Journal volume & issue
-
Vol. 6
pp.
942
– 943
WeChat QR code